2. Search Result
Search Result
Results for "

23327-57-3

" in MedChemExpress (MCE) Product Catalog:

5

Inhibitors & Agonists

3

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-B1057
    Nefopam hydrochloride
    2 Publications Verification

    Fenazoxine hydrochloride

    		 β-catenin Neurological Disease Cancer
    Nefopam hydrochloride (Fenazoxine hydrochloride) is a centrally-acting but non-opioid analgesic drug, for the relief of moderate to severe pain. Nefopam hydrochloride targets β-catenin protein level in mesenchymal cells in-vitro and in-vivo .
    Nefopam hydrochloride
  • HY-B1057S
    Nefopam-d3 hydrochloride

    Fenazoxine-d3 hydrochloride

    		 β-catenin Neurological Disease
    Nefopam-d3 (hydrochloride) is the deuterium labeled Nefopam hydrochloride. Nefopam hydrochloride (Fenazoxine hydrochloride) is a centrally-acting but non-opioid analgesic drug, for the relief of moderate to severe pain. Nefopam hydrochloride targets β-catenin protein level in mesenchymal cells in-vitro and in-vivo[1][2].
    Nefopam-d3 hydrochloride
  • HY-B1057S1
    Nefopam-d4 hydrochloride

    Fenazoxine-d4 hydrochloride

    		 Isotope-Labeled Compounds β-catenin Neurological Disease
    Nefopam-d4 (hydrochloride) is deuterium labeled Nefopam (hydrochloride). Nefopam hydrochloride (Fenazoxine hydrochloride) is a centrally-acting but non-opioid analgesic drug, for the relief of moderate to severe pain. Nefopam hydrochloride targets β-catenin protein level in mesenchymal cells in-vitro and in-vivo[1][2].
    Nefopam-d4 hydrochloride
  • HY-B1057S2
    Nefopam-d3

    Fenazoxine-d3

    		 β-catenin Neurological Disease
    Nefopam-d3 is a deuterium labeled Nefopam (Fenazoxine). Nefopam is a centrally-acting but non-opioid analgesic drug, and Nefopam targets β-catenin protein level in mesenchymal cells[1][2].
    Nefopam-d3
  • HY-133195
    Nefopam

    Fenazoxine

    		 Others Neurological Disease
    Nefopam (Fenazoxine) is an orally active, non-opioid and non-steroidal centrally acting analgesic agent. Nefopam blocks voltage-sensitive sodium channels (IC50=27 μM) and modulates glutamatergic transmission in rodents. Nefopam can be used in studies of neuropathic pain, anticonvulsant, as well as the prevention of postoperative shivering and hiccups .
    Nefopam

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: